课题基金 / 基金详情

Task X2: Feasibility and PDP support for RSV vaccines

Task X2: Feasibility and PDP support for RSV vaccines
任务 X2：RSV 疫苗的可行性和 PDP 支持
批准号：
8744682
负责人：
NORMAN KNETEMAN
金额：
$9.09万
依托单位：
ADVANCED BIOSCIENCE LABORATORIES, INC.
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
项目状态：
已结题
起止时间：
2012-09-17 至 2016-09-15
来源：
https://reporter.nih.gov/project-details/8744682
关键词：
BioterrorismClinical ResearchCommunicable DiseasesContractsCyclic GMPDevelopmentDevelopment PlansDrug resistanceEmerging Communicable DiseasesPhaseRespiratory Syncytial Virus VaccinesServicesToxicologyUnited States Food and Drug AdministrationVaccine ResearchVaccinesnovel vaccinespathogenproduct development

项目摘要

项目成果

NORMAN KNETEMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Manufacture and Characterization Services (MCS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services spanning product development planning and feasibility assessments; product development and cGMP compliant manufacture for Phase I/II clinical studies; toxicology studies; technical and facility audits; and regulatory support appropriate for submission to the U.S. Food and Drug Administration (FDA). These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism, drug-resistant pathogens, and emerging and re-emerging infectious diseases. This contract also provides for manufacture of challenge material.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TASK A92: Efficacy testing of therapeutics against Hepatitis B in a mouse model
  • 批准号：
    9355867
  • 项目类别：
  • 资助金额：
    $84.28万
  • 财政年份：
    2016
  • 负责人：
    NORMAN KNETEMAN
  • 依托单位：
    KMT HEPATECH INC
Task B12: Comprehensive Virology Panel
  • 批准号：
    8744737
  • 项目类别：
  • 资助金额：
    $58.65万
  • 财政年份：
    2013
  • 负责人：
    NORMAN KNETEMAN
  • 依托单位：
    GEORGETOWN UNIVERSITY
Task A08: In Vitro Characterization Of Antimicrobial Activity
Task A03: In Vitro Screening for Antifungal Activity
海外基金